ArticleJournal of cosmetic dermatology2025
The Role of the Glass Ceiling Syndrome in Female Healthcare Workers and Its Association With Telogen Effluvium.
Article in Journal of cosmetic dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND-
objectiveTelogen effluvium (TE) type hair loss is the most common cause of diffuse and non-scarring alopecia in women and may develop on the basis of many etiological causes. Glass ceiling syndrome, which is a popular research topic especially in recent years, is one of the syndromes that define the invisible barriers that women face in their careers and can cause long-term stress during periods of exposure. Women working in the health sector are frequently exposed to the glass ceiling, and this situation has negative effects on skin health. The aim of the study is to investigate the relationship between glass ceiling syndrome-induced stress and telogen effluvium, which has not been examined before. In addition, another aim of the study is to determine the effect of socio-demographic variables such as age, gender, and education level on stress symptoms telogen effluvium. MATERIALS AND
methodsThis study was conducted on 108 female participants working in University Hospitals. Questionnaires were used to determine how the participants experienced the glass ceiling syndrome, their professional and marital status, and their level of education. In addition, an examination including a pull test and trichoscopy for telogen effluvium disease was performed by specialized doctors.
results56 (51.85%) of 108 female health workers were diagnosed with telogen effluvium. It was determined that 73 (67.59%) of them had glass ceiling experience. Of the 108 female health workers, 36 were doctors, 44 were nurses, and 28 were other health workers. Regarding their education levels, 36 of them have a master's degree, 18 have a bachelor's degree, 34 have an associate's degree, and 20 have a high school degree. As for marital status, 71 of them were married, 24 of them were single, and 13 of them were divorced. A significant statistical relationship was found between telogen effluvium and glass ceiling syndrome and education and occupational status. At the same time, a significant statistical relationship was found between glass ceiling experience and education and occupational status.
conclusionGlass ceiling syndrome is statistically significantly associated with telogen effluvium in female health workers, and it is emphasized that this situation should not be neglected as a source of intense stress during treatment. In addition, professional and marital status and education levels are also seen to feed this intense stress source.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.